ANGEL STUDIOS INC (ANGX) Stock Fundamental Analysis

NYSE:ANGX • US0349481095

3.27 USD
+0.05 (+1.55%)
At close: Feb 13, 2026
3.4 USD
+0.13 (+3.98%)
After Hours: 2/13/2026, 8:04:00 PM
Fundamental Rating

1

Taking everything into account, ANGX scores 1 out of 10 in our fundamental rating. ANGX was compared to 80 industry peers in the Entertainment industry. ANGX may be in some trouble as it scores bad on both profitability and health. ANGX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year ANGX has reported negative net income.
ANGX Yearly Net Income VS EBIT VS OCF VS FCFANGX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 -20M -40M -60M -80M

1.2 Ratios

  • ANGX has a worse Return On Assets (-48.34%) than 87.50% of its industry peers.
  • Looking at the Return On Equity, with a value of -302.07%, ANGX is doing worse than 78.75% of the companies in the same industry.
Industry RankSector Rank
ROA -48.34%
ROE -302.07%
ROIC N/A
ROA(3y)-29.19%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ANGX Yearly ROA, ROE, ROICANGX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 500 1K 1.5K 2K

1.3 Margins

  • ANGX has a worse Gross Margin (25.73%) than 71.25% of its industry peers.
  • The Profit Margin and Operating Margin are not available for ANGX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 25.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ANGX Yearly Profit, Operating, Gross MarginsANGX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 50 -50

2

2. Health

2.1 Basic Checks

  • The number of shares outstanding for ANGX remains at a similar level compared to 1 year ago.
  • ANGX has a worse debt/assets ratio than last year.
ANGX Yearly Shares OutstandingANGX Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 50M 100M 150M
ANGX Yearly Total Debt VS Total AssetsANGX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • ANGX has an Altman-Z score of 0.45. This is a bad value and indicates that ANGX is not financially healthy and even has some risk of bankruptcy.
  • ANGX has a Altman-Z score (0.45) which is in line with its industry peers.
  • ANGX has a Debt/Equity ratio of 1.32. This is a high value indicating a heavy dependency on external financing.
  • ANGX has a worse Debt to Equity ratio (1.32) than 68.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.32
Debt/FCF N/A
Altman-Z 0.45
ROIC/WACCN/A
WACCN/A
ANGX Yearly LT Debt VS Equity VS FCFANGX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 50M -50M 100M 150M 200M

2.3 Liquidity

  • ANGX has a Current Ratio of 1.09. This is a normal value and indicates that ANGX is financially healthy and should not expect problems in meeting its short term obligations.
  • ANGX's Current ratio of 1.09 is in line compared to the rest of the industry. ANGX outperforms 48.75% of its industry peers.
  • A Quick Ratio of 1.07 indicates that ANGX should not have too much problems paying its short term obligations.
  • The Quick ratio of ANGX (1.07) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.07
ANGX Yearly Current Assets VS Current LiabilitesANGX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 20M 40M 60M 80M

3

3. Growth

3.1 Past

  • ANGX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1079.04%.
  • The Revenue for ANGX has decreased by -52.32% in the past year. This is quite bad
EPS 1Y (TTM)-1079.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-52.32%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • ANGX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.42% yearly.
  • The Revenue is expected to grow by 76.25% on average over the next years. This is a very strong growth
EPS Next Y-184.88%
EPS Next 2Y-0.51%
EPS Next 3Y13.42%
EPS Next 5YN/A
Revenue Next Year220.89%
Revenue Next 2Y108.68%
Revenue Next 3Y76.25%
Revenue Next 5YN/A

3.3 Evolution

ANGX Yearly Revenue VS EstimatesANGX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
ANGX Yearly EPS VS EstimatesANGX Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 -0.5 -1 -1.5

0

4. Valuation

4.1 Price/Earnings Ratio

  • ANGX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year ANGX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ANGX Price Earnings VS Forward Price EarningsANGX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ANGX Per share dataANGX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1

4.3 Compensation for Growth

  • ANGX's earnings are expected to grow with 13.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.51%
EPS Next 3Y13.42%

0

5. Dividend

5.1 Amount

  • ANGX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ANGEL STUDIOS INC

NYSE:ANGX (2/13/2026, 8:04:00 PM)

After market: 3.4 +0.13 (+3.98%)

3.27

+0.05 (+1.55%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)11-13
Earnings (Next)04-13
Inst Owners6.15%
Inst Owner ChangeN/A
Ins Owners5.25%
Ins Owner Change0.45%
Market Cap551.42M
Revenue(TTM)211.62M
Net Income(TTM)-95.22M
Analysts84
Price Target10.2 (211.93%)
Short Float %3.69%
Short Ratio3.53
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.23%
PT rev (3m)-28.57%
EPS NQ rev (1m)-11.25%
EPS NQ rev (3m)-17.11%
EPS NY rev (1m)11.46%
EPS NY rev (3m)2.14%
Revenue NQ rev (1m)3.02%
Revenue NQ rev (3m)22.24%
Revenue NY rev (1m)0.89%
Revenue NY rev (3m)7.72%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.61
P/FCF N/A
P/OCF N/A
P/B 17.49
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.08
EYN/A
EPS(NY)-0.54
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.25
BVpS0.19
TBVpS-0.09
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -48.34%
ROE -302.07%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 25.73%
FCFM N/A
ROA(3y)-29.19%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.07
Health
Industry RankSector Rank
Debt/Equity 1.32
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.09
Quick Ratio 1.07
Altman-Z 0.45
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)87.72%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.7%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1079.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-184.88%
EPS Next 2Y-0.51%
EPS Next 3Y13.42%
EPS Next 5YN/A
Revenue 1Y (TTM)-52.32%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year220.89%
Revenue Next 2Y108.68%
Revenue Next 3Y76.25%
Revenue Next 5YN/A
EBIT growth 1Y-859.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-46.58%
EBIT Next 3Y19.72%
EBIT Next 5YN/A
FCF growth 1Y-1233.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1118.76%
OCF growth 3YN/A
OCF growth 5YN/A

ANGEL STUDIOS INC / ANGX FAQ

What is the fundamental rating for ANGX stock?

ChartMill assigns a fundamental rating of 1 / 10 to ANGX.


Can you provide the valuation status for ANGEL STUDIOS INC?

ChartMill assigns a valuation rating of 0 / 10 to ANGEL STUDIOS INC (ANGX). This can be considered as Overvalued.


What is the profitability of ANGX stock?

ANGEL STUDIOS INC (ANGX) has a profitability rating of 0 / 10.